On-Demand Downstream Manufacturing Webinars

31. Considerations In Depth Filter Scale-Up 7/26/2024

    Explore study findings aiming to assist process development scientists and engineers in understanding the structure of depth filter capsules, identifying key parameters for development, and more.

32. Developing A Sterilizing Grade Filter For High Concentration Biologics 7/26/2024

    Explore an approach to developing a sterilizing-grade filter for high-concentration biologics that enabled extensive filterability trials to be conducted without needing a large quantity of product.

33. Virus Filtration: Regulations And Mechanisms 7/25/2024

    In this presentation, Dr. Nigel Jackson, Principal Engineer in R&D, offers an in-depth discussion on regulatory guidance and recent updates pertaining to virus filtration.

34. Accelerate Process Development With HTS Chromatography Tools 7/16/2024

    High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. Learn about a solution that addresses challenges with their use in new modalities.

35. Accelerating Drug Development For Biologics: Flexible And Fast DNA-To-IND Programs 7/8/2024

    Gain expert insights on how tailored approaches and innovative technologies enable fast and flexible development workflows, ultimately supporting rapid therapeutic breakthroughs.

36. Solving Bispecific Antibody Heavy-Light Chain Mispairing 7/3/2024

    Explore how the bYlok® bispecific pairing technology can be used to solve heavy-light chain mispairing in bispecific antibodies and how it compares with alternative scaffolds.

37. AAV Analytics: Key Considerations When Developing A Clinical Program 4/25/2024

    Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.

38. Why You Need Monoliths To Purify Your Biomolecules 4/9/2024

    Watch to learn what makes monoliths the ideal solution to the challenges of purifying large biomolecules.

39. Downstream Strategies To Accelerate Preclinical Development Timelines 4/3/2024

    As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.

40. Gain Confidence In Your ADCs With Stability Prediction Experiments 3/26/2024

    Learn more about the importance of stability experiments early in the development process for antibody drug conjugates (ADCs) with the data collected being used to mitigate stability problems during extended storage or high-concentration use of the ADC.